Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term

Diabetes

Volumn 63, Issue 6, 2014, Pages 2026-2036

  Takiishi, Tatiana ^a   Ding, Lei ^a   Baeke, Femke ^a   Spagnuolo, Isabella ^b   Sebastiani, Guido ^b   Laureys, Jos ^a   Verstuyf, Annemieke ^a   Carmeliet, Geert ^a   Dotta, Francesco ^b   Van Belle, Tom L ^a   Gysemans, Conny A ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; GAMMA INTERFERON; INSULIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; LACTATION; LONG TERM CARE; LYMPH NODE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PREGNANCY; PRIORITY JOURNAL; RISK REDUCTION; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

ANIMALS; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 1; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED NOD; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; VITAMINS;

EID: 84901323711     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1559     Document Type: Article

References (40)

1. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011;91:79-118
2. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986;314:1360-1368
3. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000;355:873-876 (Pubitemid 30137666)
4. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008;51:1391-1398
5. Vitamin D supplement in early childhood and risk for Type I (insulindependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999;42:51-54 (Pubitemid 29039737)
6. Hyppönen E. Vitamin D and increasing incidence of type 1 diabetesevidence for an association? Diabetes Obes Metab 2010;12:737-743
7. Giulietti A, Gysemans C, Stoffels K, et al. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004;47: 451-462
8. Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 2003;417:77-80
9. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000;43:1093-1098
10. Sørensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes 2012;61:175-178
11. Bruns ME, Bruns DE, Avioli LV. Vitamin D-dependent calcium-binding protein of rat intestine: changes during postnatal development and sensitivity to 1,25-dihydroxycholecalciferol. Endocrinology 1979;105:934-938 (Pubitemid 10243305)
12. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008;24: 701-706
13. Mathieu C, van Etten E, Gysemans C, Decallonne B, Bouillon R. Seasonality of birth in patients with type 1 diabetes. Lancet 2002;359:1248
14. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994;37:552-558 (Pubitemid 24162425)
15. Verhaeghe J, Van Herck E, Van Bree R, Van Assche FA, Bouillon R. Osteocalcin during the reproductive cycle in normal and diabetic rats. J Endocrinol 1989;120:143-151 (Pubitemid 19022051)
16. Lieben L, Masuyama R, Torrekens S, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 2012;122:1803-1815
17. Gysemans C, Waer M, Laureys J, et al. Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells. Clin Exp Immunol 2000;121:557-565
18. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061 (Pubitemid 36222930)
19. Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005;201:723-735 (Pubitemid 40395118)
20. Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A 2005;102:4091-4096 (Pubitemid 40388560)
21. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-58
22. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008;93:512-517 (Pubitemid 352025770)
23. Dong JY, Zhang WG, Chen JJ, Zhang ZL, Han SF, Qin LQ. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients 2013;5:3551-3562
24. Simpson M, Brady H, Yin X, et al. No association of vitamin D intake or 25- hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 2011;54:2779-2788
25. Miettinen ME, Reinert L, Kinnunen L, et al. Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia 2012;55:1291-1294
26. Gysemans CA, Cardozo AK, Callewaert H, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005;146:1956-1964
27. Fujita H, Sugimoto K, Inatomi S, et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell 2008;19:1912-1921
28. Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 2013;143:1679-1686
29. Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol Aspects Med 2012;33:77-82
30. Roy S, Shrinivas K, Bagchi B. Vitamin D sensitivity to the immune responses and autoimmunity: A chemical network model study [Internet], 2013. Ithaca, NY. Cornell University Library. Available from http://arxiv.org/abs/ 1304.7193. Accessed 13 June 2013
31. Marjamäki L, Niinistö S, Kenward MG, et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 2010;53:1599-1607
32. Brekke HK, Ludvigsson J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes 2007;8:11-14 (Pubitemid 46390381)
33. Hawa MI, Valorani MG, Buckley LR, et al. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the nonobese diabetic mouse. Horm Metab Res 2004;36:620-624 (Pubitemid 39457639)
34. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996;8:837-842 (Pubitemid 27007650)
35. Weiss L, Letimier FA, Carriere M, et al. In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2- treated HIV patients. Proc Natl Acad Sci U S A 2010;107:10632-10637
36. Casteels K, Waer M, Laureys J, et al. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation 1998;65: 1225-1232 (Pubitemid 28224342)
37. Baeke F, Korf H, Overbergh L, et al. The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2011; 186:132-142
38. Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009;183:5458-5467
39. Bouillon R, Van Schoor NM, Gielen E, et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 2013;98:E1283-E1304
40. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-210 (Pubitemid 36015393)